Our Process

The Plasma based biotherapeutics market has two segments:

plasma collection and plasma fractionation.

THE OPPORTUNITY

There is little to no collection of Plasma or manufacturing of PDMP in low-medium income countries.

PLASMA COMPOSITION

Human plasma has 35 and 10 g/L of albumin and Ig (ref.: Modern Plasma Fractionation - PMC (nih.gov)), which is approximately 80% of all plasma proteins potentially fractionated. Other plasma fractionated products are used for many other rare disease treatments like Hemophilia A.

THE PROCESS

Human plasma is collected either directly from donors using plasmaphoresis process (called as Source Plasma) or recovered through donated human blood (recovered Plasma). In human blood we have 55% plasma, 44% red blood cells and ~1% white blood cells & platelets.

Copy of AI Copy - Presentation - Idea Space Master File .png

There is an increasing geriatric population and immune deficiency diseases in low-medium income countries, these require supply reliability.

Medical Centre Presentation Template.png

GLOBAL ALBUMIN MARKET

The Global Albumin Market is expected to reach $8,956.07 million by 2030,

Growing at CAGR of 6.4% (2021- 2030).

$8.9

BILLION

2030

6.4%

CAGR

(2021 -2030)

GLOBAL IMMUNOGLOBULIN MARKET

Global Intravenous Immunoglobulin Market size in 2022 USD 12.0 billion with revenue forecast of USD 21.1 billion in 2030